Navigation Links
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

NEW YORK, Aug. 6, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019

http://www.reportlinker.com/p0869191/Hepatitis-B-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary GlobalData, the industry analysis specialist, has released its new report, "Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global hepatitis B therapeutics market. The report identifies the key trends shaping and driving the global hepatitis B therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global hepatitis B therapeutics market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's analysis shows that the global hepatitis B therapeutics market stood at $2,018.7m in 2006 and grew at a Compound Annual Growth Rate (CAGR) of 8.6% to reach $3,056.0m in 2011. GlobalData forecasts that the global hepatitis B therapeutics market will grow at a slow rate with a CAGR of 4.8% over the forecast period to reach $4,441.3m by 2019. The low growth in the global hepatitis B therapeutics market can be attributed to the high
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Celltex Therapeutics Corporation Expands Laboratory Operations And Adds Depth To Its Management Team
2. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
3. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 1
4. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
5. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
6. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
7. Juventas Therapeutics Raises $22.2 Million Series B Financing
8. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
9. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
10. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
11. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Nearly 20,000 medical professionals and healthcare leaders ... Clinical Lab Expo in Chicago ... diagnostic research and technology that will advance medicine and ... of Wednesday, July 30, more than 19,500 attendees had ... Lab Expo, with more than 10,000 of these attendees ...
(Date:7/31/2014)... the sound-processing part of the mouse brain in a ... trees in view. Their imaging technique allows zooming in ... and it enabled the team to watch brain cells ... results, which represent a step toward better understanding how ... the journal Neuron . , In the past, ...
(Date:7/31/2014)... Calif. , July 31, 2014 Rogne ... San Francisco Bay Area , has acquired a ... of Oxford,s commercialisation company. The potent anti-inflammatory activity of ... at the University of Oxford,s Sir William ... company, which has raised over $1.5 million in seed ...
(Date:7/31/2014)... 2014 Research and Markets has ... 2014-2018" report to their offering. ... study of the genetic material or genomes of an ... for the discovery and development of diagnostic and therapeutic ... conditions. Genomics is supported by three major product segments: ...
Breaking Biology Technology:Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3New mapping approach lets scientists zoom in and out as the brain processes sound 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2
... New England Biolabs has expanded its line of PCR reagents ... Start DNA Polymerases. Optimized blends of Taq and ... robust amplification across a wide range of templates, including routine, ... Vent increases the fidelity and robustness of Taq , ...
... 2011 QPS Holdings, LLC, a leading full-service ... support preclinical and clinical research and development, announced ... Preclinical Sciences (CTPS) from Taiwan,s Development Center for ... a division of QPS-Taiwan. QPS is ...
... Inc., a pharmaceutical company developing orally-available broad spectrum ... $45 million Series F financing. New Leaf Venture ... investors Pappas Ventures and Morningside Group, as well ... Partners, Asset Management Company and Frazier Healthcare Ventures. ...
Cached Biology Technology:New England Biolabs Introduces OneTaq™ DNA Polymerase, a Robust Solution for Routine and Difficult PCR 2QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan 2Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 2Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 3Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 4
(Date:7/31/2014)... adipocytes, or fat cells, are inherently different. Each of ... its own role in metabolism. In the human body, ... Its primary function is energy storage. On the other ... but are only found in a few places in ... special type of brown adipocytes, appear mixed with brown ...
(Date:7/30/2014)... the way for a breakthrough that may prevent ... to poisonous chemicalsparticularly those in pesticides and chemical ... issue of the journal ChemBioChem outlines ... commonly used in pesticides and warfare agents. The ... Engineering Associate Professor of Chemical and Biological Engineering ...
(Date:7/30/2014)... the potential effects of climate change on the ... the wrong factors, according to a new paper ... Society, University of Queensland, and other organizations. The ... is missing the point when it comes to ... climate change scientists focus on the "direct" threats ...
Breaking Biology News(10 mins):Hope for the overweight 2Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
... This release is available in German . ... Zentrum Mnchen, the German Center for Neurodegenerative Diseases (DZNE) and ... have now discovered that lipid peroxides* play a specific physiological ... already established that accumulation of lipid peroxides* indicate cell stress. ...
... new study shows that male rats prenatally exposed to low ... to develop prostate inflammation and to go through puberty later ... of literature on atrazine, an herbicide predominantly used to control ... cane. Atrazine and its byproducts are known to be relatively ...
... a half billion years ago, Earth differed greatly from ... of gases in the atmosphere and the nature of ... consists of about 21 percent oxygen, the ancient atmosphere ... organisms. The complex eukaryotic life we are familiar with ...
Cached Biology News:Lipid peroxides -- more sophisticated than their reputation 2Atrazine causes prostate inflammation in male rats and delays puberty 2Ancient microbes responsible for breathing life into ocean 'deserts' 2Ancient microbes responsible for breathing life into ocean 'deserts' 3Ancient microbes responsible for breathing life into ocean 'deserts' 4
... contains sufficient materials for 1,464 array sample elements. ... , Blocker BSA in PBS (10X): ... HRP-conjugated: 10 g , BupH Phosphate ... Tween-20: 2 x 10 ml ampules , SuperSignal ...
... The Partec Cell Counter Analyser counts ... that the CCA detects only cells, so ... influence the results.,While passing through a 250 ... a fluorescence light signal which is used ...
... system, 100-120 V, is used for biolistic ... handheld device employs an adjustable helium pulse ... gold microcarriers from the inner wall of ... cells. This system has a 2 square-centimeter ...
... Results Laser Capture Microdissection (LCM) enables ... accuracy of molecular assays by starting with ... structures isolated from whole tissue or cytology ... 1996 at the National Institutes of Health ...
Biology Products: